Laxmi Dental Reports Record Q4 Revenue of ₹74 Cr, PAT Surges 134.9%

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Laxmi Dental Reports Record Q4 Revenue of ₹74 Cr, PAT Surges 134.9%
Overview

Laxmi Dental posted its highest-ever quarterly revenue of ₹74 crore in Q4 FY26, a 21.9% jump year-on-year. Net profit more than doubled to ₹10.1 crore. The company highlighted strong growth in its domestic and international businesses, a debt-free status with significant cash reserves, and progress in its digital strategy.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Laxmi Dental Limited: Record Q4 Revenue and Profit Growth

₹74 crore in Q4 FY26 revenue and ₹10.1 crore in Q4 FY26 PAT.

Reader Takeaway: Record revenue and PAT growth driven by digital strategy; watch supply chain and tariff risks.

What just happened

Laxmi Dental Limited announced its financial results for the fourth quarter and full year ended March 31, 2026. The company achieved its highest-ever quarterly revenue of ₹74 crore in Q4 FY26, a significant increase of 21.9% compared to ₹60.7 crore in Q4 FY25. Profit After Tax (PAT) for the quarter surged by 134.9% to ₹10.1 crore, up from ₹4.3 crore in the same period last year. The full-year FY26 revenue reached ₹277.9 crore, marking a 16.2% growth.

Why this matters

This performance signifies strong demand for Laxmi Dental's products and successful execution of its growth strategies, particularly its digital dentistry initiatives. The substantial profit jump indicates improved operational efficiency and a healthy margin expansion. Maintaining a debt-free status with substantial cash reserves provides financial resilience and flexibility for future investments.

The backstory

The company has been focusing on expanding its presence in both domestic and international markets. Its digital penetration in the domestic lab business has reached 80%, indicating a successful shift towards more efficient and potentially higher-margin digital models. The international lab business saw a robust 40.9% year-on-year growth.

What changes now

With record quarterly performance and sustained growth, Laxmi Dental is poised for further expansion. Management expects EBITDA margins to remain stable in the current range due to automation and operational leverage. New product launches like 'iScope 360' are expected to contribute to future revenue streams.

Risks to watch

Supply chain disruptions, particularly shipment delays due to high freight costs, were noted for the Vedia business in March. Additionally, the company has a 10% exposure to potential US tariffs, which could pose a regulatory and trade risk to its international operations.

Peer comparison

Laxmi Dental's focus on digital dentistry and its debt-free status with significant cash reserves position it uniquely. Growth in international segments and margin stability are key metrics to watch against peers in the dental products and services sector.

Context metrics (time-bound)

  • Q4 FY26 Revenue: ₹74 crore (up 21.9% YoY)
  • FY26 Revenue: ₹277.9 crore (up 16.2% YoY)
  • Q4 FY26 PAT: ₹10.1 crore (up 134.9% YoY)
  • Q4 FY26 EBITDA Margin: 18.3%
  • Cash/Investments: ₹99 crore (Debt-free)
  • Domestic Lab Digital Penetration: 80%

What to track next

Investors will be closely watching the company's progress on international regulatory registrations, its ability to sustain the achieved EBITDA margins, and its management of supply chain and tariff-related risks. The performance of new products and continued growth in international markets will also be critical.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.